Correction to the article “Viscoelastic Tests in the Evaluation of Haemostatic Disorders in SARS-CoV-2 Infection”, Published on Acta Med Port 2021 Jan;34(1):35-46.

• Autor(es): de Sousa, Carla
• Data: 2021
• Origem: Acta Médica Portuguesa
• Tipo de Documento: Artigo científico
• Idioma: Inglês

Descrição

On page 36, in the fifth sentence of right-side column, where it reads: ”Direct thrombin inhibitors (DTI) (argatroban, bivalirrubin) are used in COVID-19 infected patients with significantly lower antithrombin levels,24 or if heparin induced thrombocytopenia (HIT) occurs.”It should read: “Direct thrombin inhibitors (DTI) (argatroban, bivalirudin) are used in COVID-19 infected patients with significantly lower antithrombin levels,24 or if heparin induced thrombocytopenia (HIT) occurs.”Article published with errors: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/14784

Na página 36, quinto parágrafo da coluna do lado direito, onde se lê: “Direct thrombin inhibitors (DTI) (argatroban, bivalirrubin) are used in COVID-19 infected patients with significantly lower antithrombin levels,24 or if heparin induced thrombocytopenia (HIT) occurs.”Deverá ler-se: “Direct thrombin inhibitors (DTI) (argatroban, bivalirudin) are used in COVID-19 infected patients with significantly lower antithrombin levels,24 or if heparin induced thrombocytopenia (HIT) occurs.”Artigo publicado com erros: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/14784